EPISODE · May 7, 2026 · 1 MIN
Mounjaro Tops Drug Sales, Lilly's Stock Soars
from The Daily News Now! Business
Eli Lillys Mounjaro skyrocketed to the top spot as the worlds best-selling drug, raking in a whopping $8.66 billion in Q1 sales, surpassing Mercks Keytruda by $7.9 billion. This surge more than doubled from last years $3.84 billion, driving Lillys total revenue up by 56% to $19.79 billion and net income soaring by 168%. Zepbound contributed $4.16 billion, and international sales boomed, particularly in China, which added Mounjaro to its reimbursement list, now reaching over 55 countries. With obesity affecting 16% of the global population, or over 1 billion people, demand for Mounjaro remains high, especially in the U.S., where 40.3% of adults qualify. Lillys new oral obesity pill Foundayo launched in April, already with 20,000 users and 8,000 doctors prescribing it, setting up revenue projections at $84.4 billion by 2027. The stock is looking promising for the long haul. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/2a18b5f08f99547c
NOW PLAYING
Mounjaro Tops Drug Sales, Lilly's Stock Soars
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m